Precipio, Inc. (PRPO)

USD 7.32

(15.26%)

Total Liabilities Summary of Precipio, Inc.

  • Precipio, Inc.'s latest annual total liabilities in 2023 was 3.67 Million USD , down -28.52% from previous year.
  • Precipio, Inc.'s latest quarterly total liabilities in 2024 Q1 was 3.85 Million USD , up 4.85% from previous quarter.
  • Precipio, Inc. reported annual total liabilities of 5.13 Million USD in 2022, down -11.96% from previous year.
  • Precipio, Inc. reported annual total liabilities of 5.83 Million USD in 2021, down -10.93% from previous year.
  • Precipio, Inc. reported quarterly total liabilities of 5.2 Million USD for 2024 Q2, up 35.14% from previous quarter.
  • Precipio, Inc. reported quarterly total liabilities of 6.05 Million USD for 2023 Q3, up 12.45% from previous quarter.

Annual Total Liabilities Chart of Precipio, Inc. (2023 - 1999)

Historical Annual Total Liabilities of Precipio, Inc. (2023 - 1999)

Year Total Liabilities Total Liabilities Growth
2023 3.67 Million USD -28.52%
2022 5.13 Million USD -11.96%
2021 5.83 Million USD -10.93%
2020 6.55 Million USD 3.89%
2019 6.3 Million USD -59.27%
2018 15.48 Million USD 8.76%
2017 14.23 Million USD -30.93%
2016 20.6 Million USD 16.86%
2015 17.63 Million USD -24.8%
2014 23.45 Million USD 24.54%
2013 18.83 Million USD 1.7%
2012 18.51 Million USD -17.75%
2011 22.51 Million USD -4.31%
2010 23.52 Million USD 441.85%
2009 4.34 Million USD -0.21%
2008 4.35 Million USD -12.77%
2007 4.98 Million USD -6.4%
2006 5.32 Million USD -28.32%
2005 7.43 Million USD -64.47%
2004 20.92 Million USD 70.83%
2003 12.24 Million USD -2.18%
2002 12.52 Million USD 74.34%
2001 7.18 Million USD 84.3%
2000 3.89 Million USD -82.34%
1999 22.06 Million USD 0.0%

Peer Total Liabilities Comparison of Precipio, Inc.

Name Total Liabilities Total Liabilities Difference
Aclaris Therapeutics, Inc. 40.22 Million USD 90.872%
Applied DNA Sciences, Inc. 8.77 Million USD 58.174%
Aspira Women's Health Inc. 8.62 Million USD 57.436%
Biodesix, Inc. 94.51 Million USD 96.115%
BioNexus Gene Lab Corp. 1.74 Million USD -110.799%
bioAffinity Technologies, Inc. 3.36 Million USD -9.081%
bioAffinity Technologies, Inc. 3.36 Million USD -9.081%
Bionano Genomics, Inc. 118.24 Million USD 96.895%
CareDx, Inc 223.28 Million USD 98.355%
Check-Cap Ltd. 1.33 Million USD -176.09%
Castle Biosciences, Inc. 86.54 Million USD 95.757%
DarioHealth Corp. 38.24 Million USD 90.399%
Exact Sciences Corporation 3.32 Billion USD 99.89%
Fulgent Genetics, Inc. 139.82 Million USD 97.374%
Guardant Health, Inc. 1.62 Billion USD 99.774%
ICON Public Limited Company 7.74 Billion USD 99.953%
IDEXX Laboratories, Inc. 1.77 Billion USD 99.793%
Illumina, Inc. 4.36 Billion USD 99.916%
Intelligent Bio Solutions Inc. 5.59 Million USD 34.378%
iSpecimen Inc. 6.07 Million USD 39.586%
Standard BioTools Inc. 159.86 Million USD 97.703%
MDxHealth SA 121.92 Million USD 96.988%
23andMe Holding Co. 206.64 Million USD 98.223%
Medpace Holdings, Inc. 1.09 Billion USD 99.666%
Myriad Genetics, Inc. 312.9 Million USD 98.826%
Mainz Biomed B.V. 12.15 Million USD 69.802%
ENDRA Life Sciences Inc. 1.09 Million USD -235.294%
NeoGenomics, Inc. 739.69 Million USD 99.504%
Neogen Corporation 1.44 Billion USD 99.745%
Inotiv, Inc. 588.04 Million USD 99.376%
Natera, Inc. 691.79 Million USD 99.469%
OPKO Health, Inc. 622.47 Million USD 99.41%
Psychemedics Corporation 6.59 Million USD 44.347%
Prenetics Global Limited 44.01 Million USD 91.657%
Prenetics Global Limited 44.01 Million USD 91.657%
Personalis, Inc. 95.65 Million USD 96.161%
RadNet, Inc. 2.07 Billion USD 99.823%
Sera Prognostics, Inc. 25.28 Million USD 85.476%
Sotera Health Company 2.68 Billion USD 99.863%
Neuronetics, Inc. 81.64 Million USD 95.502%
Star Equity Holdings, Inc. 21.67 Million USD 83.059%
Star Equity Holdings, Inc. 21.67 Million USD 83.059%
Trinity Biotech plc 83.38 Million USD 95.596%
Twist Bioscience Corporation 152.97 Million USD 97.6%
Exagen Inc. 34.25 Million USD 89.279%